(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide sodium salt
Grundinformationen
- CAS
1051375-19-9- Standard-SMILES
C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12.[Na]- InChIKey
FOZLBAIXQATFFW-VSLILLSYSA-N- Summenformel
- C20H19F2N3NaO5
- Durchschnittliche Molmasse
- 442,4 g/mol
Namen und Bezeichner
- Bevorzugter Name
- (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide sodium salt
- Englischer Name
- Dolutegravir sodium
- Summenformel
- C20H20F2N3NaO5
- Molmasse
- 443.38
Namen und Synonyme
SCHEMBL1835959FOZLBAIXQATFFW-VSLILLSYSA-NBSB37519(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide sodium saltDOLUTEGRAVIR SODIUMDolutegravir sodiuM saltDolutegravi SodiumGSK1349572 sodiuM saltGSK1349572 sodiuM salt USP/EP/BPSodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate158439GSK 1349572A
Weitere Namen anzeigen
Dulutevir sodiumDulutewei sodium salt
Datenbank-Bezeichner
- CAS
1051375-19-9- PubChem CID
- 67179015
Eigenschaften
Berechnete Struktureigenschaften
- Polarare Oberfläche (TPSA)
- 99,2 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 8
- Frei drehbare Bindungen
- 3
- Schwere Atome
- 31
- Formalladung
- 0
- Komplexität
- 829
Physikochemische Eigenschaften
- Schmelzpunkt
- 300 oC · >300oC
- storage temp.
- -20 °C · Hygroscopic, -20°C Freezer, Under inert atmosphere
- Löslichkeit
- DMSO (Slightly, Heated), Methanol (Slightly, Heated)
- Aggregatzustand
- Solid
- Farbe
- White to Green
- Stabilität
- Hygroscopic
- InChIKey
- FWLDGCYHMZPGGI-SBBUJZKLNA-N
- SMILES
- O=C1N2[C@@H](CCO[C@@]2([H])CN2C=C(C(=O)NCC3C=CC(F)=CC=3F)C(=O)C(O)=C12)C.[NaH] |&1:3,7,r|
Sicherheit und Regulatorisches
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Sicherheitsdaten
- Alarmwort
- Warnung
- Gefahrenhinweise
- Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H400
Chemie und Industrie
Anwendungen
BeschreibungDolutegravir, also known as DTG or dolutegravir sodium, is an antiretroviral therapy drug used to treat HIV infection. It belongs to the Integrase Strand Transfer inhibitor (INSTi) class of drugs and was fast-tracked by the FDA in February 2012. GlaxoSmithKline developed and markets dolutegravir sodium (Tivicay), which received FDA approval in August 2013 as a novel integrase inhibitor for HIV treatment, including adults undergoing their first treatment as well as those who have been treated with other integrase transfer strand inhibiting agents.
VerwendenDolutegravir, a second-generation HIV-1 integrase strand transfer inhibitor, is commonly used along with other medications to manage HIV infection. Its potency in inhibiting HIV replication has been demonstrated in various cell types infected with a self-inactivating PHIV lentiviral vector, including peripheral blood mononuclear cells (PBMCs), MT-4 cells, and CIP4 cells.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Ergänzende Hinweise
DefinitionChEBI: Dolutegravir sodium is an organic sodium salt that is the monosodium salt of dolutegravir. Used for treatment of HIV-1. It has a role as a HIV-1 integrase inhibitor. It contains a dolutegravir(1-).
Anbieter
Wird geladen…
Öffentliche Anfragen
Wird geladen…
Zugehörige Reaktionen
1
Notizen zur Verbindung
Wird geladen…